23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Gossamer Bio, Inc. › 2025-2026

Gossamer Bio, Inc. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Gossamer Bio, Inc.’s Form 8-K, filed June 5, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 4Ballot items
  • 134Asset managers, any item
  • 605Fund votes
  • June 4, 2026Meeting date

Results at a glance

Meeting of June 4, 2026: 4 items on Gossamer Bio, Inc.’s Form 8-K, filed June 5, 2026: 2 approved · 2 passed (calculated).

Dissent

Significant dissent: 2 directors (25.2%, 22.4% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Gossamer Bio, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Gossamer Bio, Inc.

These tallies are Gossamer Bio, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Gossamer Bio, Inc. — official shareholder meeting results, meeting held June 4, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Faheem Hasnain 92,301,637---- 26,667,87645,450,098 78%Passed (calculated)—
Elect Director: Russell Cox 88,975,980---- 29,993,53345,450,098 75%Passed (calculated)—
2. The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 163,185,9931,192,44841,170 ---- 99.3%Approved—
3. The approval, on an advisory basis, of the compensation of the Company's named executive officers 111,286,5507,545,502137,461 --45,450,098 94%Approved—

Source: Gossamer Bio, Inc., Form 8-K, filed with the SEC on June 5, 2026 — read the filing on EDGAR.

How asset managers voted at the Gossamer Bio, Inc. 2025-2026 meeting

134 asset managers disclosed a vote on at least one Gossamer Bio, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Russell Cox

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 5 wordings of this item as funds reported it.

75% Majority: yes · of votes cast

FOR 75%WITHHELD
FOR: 88,975,980WITHHELD: 29,993,533
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of Class II Directors: Russell Cox

Gossamer Bio, Inc.’s own tally for this item (“Elect Director: Russell Cox”): 88,975,980 for, 29,993,533 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 16,776,841 for, 1,679,536 withheld, 90 abstained.

FOR
FOR: 16,776,841ABSTAIN: 90WITHHOLD: 1,679,536
Largest asset managers voting on “Election of Class II Directors: Russell Cox” at Gossamer Bio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,876,4610 00For
Vanguard5,217,6030 9019,751For
Fidelity3,579,4730 00For
Voya950,0470 00For
Charles Schwab00 0625,721Withhold
Invesco413,5580 00For
Equitable61,9260 0122,150Mixed
Goldman Sachs180,0370 00For
SEI00 0159,516Withhold
PACE SELECT ADVISORS TRUST00 0145,404Withhold
Lincoln Financial138,6000 00For
TIAA132,8940 00For
CLEARWATER INVESTMENT TRUST00 0114,037Withhold
AIG/SunAmerica00 093,852Withhold
Global X00 084,051Withhold
ETFis Series Trust I00 072,154Withhold
QUANTITATIVE MASTER SERIES LLC69,1520 00For
John Hancock00 054,021Withhold
State Street47,3030 00For
Russell Investments00 046,319Withhold
Blackstone Alternative Investment Funds00 042,900Withhold
Bridge Builder Trust36,5240 00For
DWS00 027,319Withhold
Pacific Life18,2330 00For
Principal00 017,586Withhold

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Elect Director: Faheem Hasnain

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 5 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%WITHHELD
FOR: 92,301,637WITHHELD: 26,667,876
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of Class II Directors: Faheem Hasnain

Gossamer Bio, Inc.’s own tally for this item (“Elect Director: Faheem Hasnain”): 92,301,637 for, 26,667,876 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 16,861,827 for, 1,594,558 withheld, 82 abstained.

FOR
FOR: 16,861,827ABSTAIN: 82WITHHOLD: 1,594,558
Largest asset managers voting on “Election of Class II Directors: Faheem Hasnain” at Gossamer Bio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,876,4610 00For
Vanguard5,217,6110 8219,751For
Fidelity3,579,4730 00For
Voya00 0950,047Withhold
Charles Schwab625,7210 00For
Invesco413,5580 00For
Equitable184,0760 00For
Goldman Sachs180,0370 00For
SEI159,5160 00For
PACE SELECT ADVISORS TRUST00 0145,404Withhold
Lincoln Financial138,6000 00For
TIAA132,8940 00For
CLEARWATER INVESTMENT TRUST00 0114,037Withhold
AIG/SunAmerica00 093,852Withhold
Global X84,0510 00For
ETFis Series Trust I00 072,154Withhold
QUANTITATIVE MASTER SERIES LLC69,1520 00For
John Hancock00 054,021Withhold
State Street47,3030 00For
Russell Investments46,3190 00For
Blackstone Alternative Investment Funds00 042,900Withhold
Bridge Builder Trust36,5240 00For
DWS00 027,319Withhold
Pacific Life18,2330 00For
Principal00 017,586Withhold

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

The approval, on an advisory basis, of the compensation of the Company's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

94% Approved · of votes cast

FOR 94%
FOR: 111,286,550AGAINST: 7,545,502

Prior year: 97.1% for (June 25, 2025 meeting) ▼ 3.4 pts

Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.

Gossamer Bio, Inc.’s own tally for this item (“3. The approval, on an advisory basis, of the compensation of the Company's named executive officers”): 111,286,550 for, 7,545,502 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The compensation of the named executive officers was approved, on an advisory basis, by the votes indicated:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 39 asset managers voting on “APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN ” at Gossamer Bio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,876,4610 00For
Vanguard5,230,8746,569 00For
Fidelity3,579,4730 00For
Voya950,0470 00For
Charles Schwab625,7210 00For
Invesco0413,558 00Against
Equitable184,0760 00For
Goldman Sachs180,0370 00For
SEI0159,516 00Against
PACE SELECT ADVISORS TRUST145,4040 00For
Lincoln Financial138,6000 00For
TIAA132,8940 00For
CLEARWATER INVESTMENT TRUST114,0370 00For
AIG/SunAmerica93,8520 00For
Global X084,051 00Against
ETFis Series Trust I72,1540 00For
QUANTITATIVE MASTER SERIES LLC69,1520 00For
John Hancock54,0210 00For
State Street47,3030 00For
Russell Investments046,319 00Against
Blackstone Alternative Investment Funds42,9000 00For
Bridge Builder Trust36,5240 00For
DWS27,3190 00For
Pacific Life18,2330 00For
Principal17,5860 00For

Fund voting reports, all 39 managers: 17,718,369 for, 737,791 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 107 asset managers voting on “APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN ” at Gossamer Bio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Kalehua Capital Management LLC9,975,2920 00For
ARCH Venture Management, LLC8,055,9160 00For
AQR7,819,8570 00For
Octagon Capital Advisors LP7,700,3420 00For
Samsara BioCapital, LLC7,222,5590 00For
Siren, L.L.C.5,118,0740 00For
683 Capital Management, LLC4,995,3730 00For
HHLR ADVISORS, LTD.4,974,0410 00For
GEODE CAPITAL MANAGEMENT, LLC4,272,5810 00For
State Street4,009,1721,475 00For
BlackRock3,762,5971,450 00For
Two Sigma2,484,4060 00For
BALYASNY ASSET MANAGEMENT L.P.02,174,633 00Against
ACADIAN ASSET MANAGEMENT LLC2,131,0470 00For
Alyeska Investment Group, L.P.01,940,489 00Against
Ensign Peak Advisors, Inc1,702,1250 00For
Rock Springs Capital Management LP1,254,4600 00For
JACOBS LEVY EQUITY MANAGEMENT, INC1,247,3850 00For
NEA Management Company, LLC1,000,0000 00For
Voya950,0470 00For
Northern Trust736,7810 00For
Corient Private Wealth LP721,0200 00For
MELLON INVESTMENTS Corp662,2600 00For
Charles Schwab626,2460 00For
Connor, Clark & Lunn Investment Management Ltd.491,4520 00For

Institutional-manager reports, all 107 managers: 84,586,241 for, 4,928,132 against, 4,626 abstained. Showing the 25 largest; every one is in the interactive database (link above).

The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.3% Approved · of votes cast

FOR 99.3%
FOR: 163,185,993AGAINST: 1,192,448

Prior year: 99.9% for (June 25, 2025 meeting) ▼ 0.7 pts

Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accountants for the year ending December 31, 2026.

Gossamer Bio, Inc.’s own tally for this item (“2. The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 163,185,993 for, 1,192,448 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The selection was ratified by the votes indicated:”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 18,456,466 for.

FOR
FOR: 18,456,466
Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as our independent registered public accountants for the ” at Gossamer Bio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock5,876,4610 00For
Vanguard5,237,4430 00For
Fidelity3,579,4730 00For
Voya950,0470 00For
Charles Schwab625,7210 00For
Invesco413,5580 00For
Equitable184,0760 00For
Goldman Sachs180,0370 00For
SEI159,5160 00For
PACE SELECT ADVISORS TRUST145,4040 00For
Lincoln Financial138,6000 00For
TIAA132,8940 00For
CLEARWATER INVESTMENT TRUST114,0370 00For
AIG/SunAmerica93,8520 00For
Global X84,0510 00For
ETFis Series Trust I72,1540 00For
QUANTITATIVE MASTER SERIES LLC69,1520 00For
John Hancock54,0210 00For
State Street47,3030 00For
Russell Investments46,3190 00For
Blackstone Alternative Investment Funds42,9000 00For
Bridge Builder Trust36,5240 00For
DWS27,3190 00For
Pacific Life18,2330 00For
Principal17,5860 00For

Showing the 25 largest of 40 asset managers. All 40 are in the interactive database (link above).

Largest Gossamer Bio, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 234,696,281 shares outstanding at the time of that meeting.

Fund voting reports: top Gossamer Bio, Inc. shareholders by shares voted on “APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS…”, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 2.50%
2Vanguard 2.23%
3Fidelity 1.53%
4Voya 0.40%
5Charles Schwab 0.27%
6Invesco 0.18%
7Equitable 0.08%
8Goldman Sachs 0.08%
9SEI 0.07%
10PACE SELECT ADVISORS TRUST 0.06%
Institutional-manager reports: top Gossamer Bio, Inc. shareholders by shares voted on “APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS…”, 2025-2026
#Asset manager % of shares outstanding
1Kalehua Capital Management LLC 4.25%
2ARCH Venture Management, LLC 3.43%
3AQR 3.33%
4Octagon Capital Advisors LP 3.28%
5Samsara BioCapital, LLC 3.08%
6Siren, L.L.C. 2.18%
7683 Capital Management, LLC 2.13%
8HHLR ADVISORS, LTD. 2.12%
9GEODE CAPITAL MANAGEMENT, LLC 1.82%
10State Street 1.71%

Reported Gossamer Bio, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Gossamer Bio, Inc. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
683 Capital Management, LLC49,868,571 21.25%Schedule 13G, filed June 11, 2026
Context Capital Management, LLC48,835,788 20.81%Schedule 13G, filed June 9, 2026
DeepCurrents Investment Group LLC37,665,073 16.05%Schedule 13G, filed June 11, 2026
D. E. Shaw Valence Portfolios, L.L.C.27,698,267 11.80%Schedule 13D, filed August 24, 2026
Opaleye Management Inc.24,942,565 10.63%Schedule 13G, filed July 29, 2026
BlackRock16,826,695 7.17%Form 13F, quarter ended March 31, 2026
Vanguard Group12,873,209 5.49%Form 13F, quarter ended March 31, 2026
Geode Capital4,939,691 2.10%Form 13F, quarter ended March 31, 2026
Two Sigma4,780,851 2.04%Form 13F, quarter ended March 31, 2026
State Street4,388,109 1.87%Form 13F, quarter ended March 31, 2026

Percentages above are of 234,696,281 shares outstanding, as reported by Gossamer Bio, Inc. on its Form 10-Q dated May 12, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Gossamer Bio, Inc.'s shareholder meeting held June 4, 2026, in the 2025-2026 proxy season, 134 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 605 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS… — Gossamer Bio, Inc.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Gossamer Bio, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Gossamer Bio, Inc.’s 10-Q dated May 12, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Gossamer Bio, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Gossamer Bio (GOSS) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/gossamer-bio-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.